Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > BROWSE ARTICLES > Author index
Search
Nicole M. Iñiguez-Ariza  (Iñiguez-Ariza NM) 1 Article
Thyroid
Management of Low-Risk Papillary Thyroid Cancer
Nicole M. Iñiguez-Ariza, Juan P. Brito
Endocrinol Metab. 2018;33(2):185-194.   Published online June 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.2.185
  • 6,669 View
  • 105 Download
  • 35 Web of Science
  • 34 Crossref
AbstractAbstract PDFPubReader   ePub   

The incidence of thyroid cancer has increased, mainly due to the incidental finding of low-risk papillary thyroid cancers (PTC). These malignancies grow slowly, and are unlikely to cause morbidity and mortality. New understanding about the prognosis of tumor features has led to reclassification of many tumors within the low-risk thyroid category, and to the development of a new one “very low-risk tumors.” Alternative less aggressive approaches to therapy are now available including active surveillance and minimally invasive interventions. In this narrative review, we have summarized the available evidence for the management of low-risk PTC.

Citations

Citations to this article as recorded by  
  • Risk of malignancy in Thy3 thyroid nodules
    Emad Mofid Nassif Rezkallah, Ragai Sobhi Hanna, Wael Magdy Elsaify
    Endocrine Regulations.2024; 58(1): 19.     CrossRef
  • Adequacy of clinical guideline recommendations for patients with low-risk cancer managed with monitoring: systematic review
    Kiana K. Collins, Claire Friedemann Smith, Tori Ford, Nia Roberts, Brian D. Nicholson, Jason L. Oke
    Journal of Clinical Epidemiology.2024; 169: 111280.     CrossRef
  • Integrated metabolic and genetic analysis reveals distinct features of human differentiated thyroid cancer
    Eduardo Cararo Lopes, Akshada Sawant, Dirk Moore, Hua Ke, Fuqian Shi, Saurabh Laddha, Ying Chen, Anchal Sharma, Jake Naumann, Jessie Yanxiang Guo, Maria Gomez, Maria Ibrahim, Tracey L. Smith, Gregory M. Riedlinger, Edmund C. Lattime, Stanley Trooskin, Shr
    Clinical and Translational Medicine.2023;[Epub]     CrossRef
  • Clinical management of low-risk papillary thyroid microcarcinoma
    Chie MASAKI, Kiminori SUGINO, Koichi ITO
    Minerva Endocrinology.2022;[Epub]     CrossRef
  • The circ_FAM53B-miR-183-5p-CCDC6 axis modulates the malignant behaviors of papillary thyroid carcinoma cells
    Chong Zhang, Huxia Gu, Dingrong Liu, Fuyun Tong, Huijie Wei, Dan Zhou, Jing Fang, Xiaolu Dai, Haibo Tian
    Molecular and Cellular Biochemistry.2022; 477(11): 2627.     CrossRef
  • An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non–Thyroid Endocrine Neoplasms
    Aadil Adnan, Shobhana Raju, Rakesh Kumar, Sandip Basu
    PET Clinics.2022; 17(3): 343.     CrossRef
  • A Narrative Review of Preventive Central Lymph Node Dissection in Patients With Papillary Thyroid Cancer - A Necessity or an Excess
    David D. Dolidze, Alexey V. Shabunin, Robert B. Mumladze, Arshak V. Vardanyan, Serghei D. Covantsev, Alexander M. Shulutko, Vasiliy I. Semikov, Khalid M. Isaev, Airazat M. Kazaryan
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Ethanol Ablation as a Treatment in a Low-Risk Follicular Thyroid Cancer: A Case Report
    Juan Pesantez, Carla Lituma, Carla Valencia, Jose Prieto, Marco Cazorla
    Cureus.2022;[Epub]     CrossRef
  • The new T3b category has clinical significance? SEER‐based study
    Jingzhe Xiang, Zhihong Wang, Wei Sun, Hao Zhang
    Clinical Endocrinology.2021; 94(3): 449.     CrossRef
  • Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study
    Xiao-Jing Cao, Juan Liu, Ya-Lin Zhu, Lu Qi, Geng Liu, Hong-Ling Wang, Zhong-Hua Wang, Ying Zhou, Jun-Feng He, Jian-Qin Guo, Li-Li Shi, Mei Jian, Aini Shataer, Guo-Zhen Yan, Zhen-Long Zhao, Ying Wei, Li-Li Peng, Yan Li, Ying Che, Shu-Rong Wang, Ming-An Yu
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(2): e573.     CrossRef
  • A Clinical Audit of Hemithyroidectomy for Differentiated Thyroid Cancer—Experience from a Tertiary Cancer Center
    Nithyanand Chidambaranathan, Shivakumar Thiagarajan, Nandini Menon, Adhara Chakraborthy, Richa Vaish, Devendra Chaukar
    Indian Journal of Surgery.2021; 83(6): 1444.     CrossRef
  • Pros and cons of hemi‐thyroidectomy for low‐risk differentiated thyroid cancer
    Alexander J. Papachristos, Anthony Glover, Mark S. Sywak, Stan B. Sidhu
    ANZ Journal of Surgery.2021; 91(9): 1704.     CrossRef
  • Lactate Dehydrogenase A as a Potential New Biomarker for Thyroid Cancer
    Eun Jeong Ban, Daham Kim, Jin Kyong Kim, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung, Kunhong Kim
    Endocrinology and Metabolism.2021; 36(1): 96.     CrossRef
  • Taraxasterol inhibits TGF-β1-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt/β-catenin signaling
    J Zhu, X Li, S Zhang, J Liu, X Yao, Q Zhao, B Kou, P Han, X Wang, Y Bai, Z Zheng, C Xu
    Human & Experimental Toxicology.2021; 40(12_suppl): S87.     CrossRef
  • Is Delayed Papillary Thyroid Cancer Surgery Associated with Higher Mortality Risk?
    Eddy P. Lincango Naranjo, Juan P. Brito
    Clinical Thyroidology.2021; 33(9): 400.     CrossRef
  • MicroRNA-99a-3p/GRP94 axis affects metastatic progression of human papillary thyroid carcinoma by regulating ITGA2 expression and localization
    Yun Gao, Yi Pan, Tingting Wang, Ying Yao, Wenbo Yuan, Xue Zhu, Ke Wang
    Acta Biochimica et Biophysica Sinica.2021; 53(12): 1650.     CrossRef
  • Microscopic Extrathyroidal Extension Results in Increased Rate of Tumor Recurrence and Is an Independent Predictor of Patient’s Outcome in Middle Eastern Papillary Thyroid Carcinoma
    Sandeep Kumar Parvathareddy, Abdul K. Siraj, Zeeshan Qadri, Felisa DeVera, Khawar Siddiqui, Saif S. Al-Sobhi, Fouad Al-Dayel, Khawla S. Al-Kuraya
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • New paradigms in the treatment of low-risk thyroid cancer
    Firas Baidoun, Anas M. Saad, Omar Abdel-Rahman
    Expert Review of Endocrinology & Metabolism.2020; 15(4): 251.     CrossRef
  • The Impact of Transcription Factor Prospero Homeobox 1 on the Regulation of Thyroid Cancer Malignancy
    Magdalena Rudzińska, Barbara Czarnocka
    International Journal of Molecular Sciences.2020; 21(9): 3220.     CrossRef
  • Modified risk stratification based on cervical lymph node metastases following lobectomy for papillary thyroid carcinoma
    Eyun Song, Jonghwa Ahn, Dong Eun Song, Won Woong Kim, Min Ji Jeon, Tae‐Yon Sung, Tae Yong Kim, Ki Wook Chung, Won Bae Kim, Young Kee Shong, Suck Joon Hong, Yu‐Mi Lee, Won Gu Kim
    Clinical Endocrinology.2020; 92(4): 358.     CrossRef
  • Clinicopathological significance of the single nucleotide polymorphism, rs2853669 within the TERT promoter in papillary thyroid carcinoma
    Tatsuya Hirokawa, Yuu Arimasu, Tomohiro Chiba, Masachika Fujiwara, Hiroshi Kamma
    Pathology International.2020; 70(4): 217.     CrossRef
  • Diagnostic accuracy and ability to reduce unnecessary FNAC: A comparison between four Thyroid Imaging Reporting Data System (TI-RADS) versions
    Lingsze Tan, Ying Sern Tan, Suzet Tan
    Clinical Imaging.2020; 65: 133.     CrossRef
  • Amino Acid Transporters as Potential Therapeutic Targets in Thyroid Cancer
    Keisuke Enomoto, Muneki Hotomi
    Endocrinology and Metabolism.2020; 35(2): 227.     CrossRef
  • FDG PET/CT versus somatostatin receptor PET/CT in TENIS syndrome: a systematic review and meta-analysis
    Felipe Alves Mourato, Maria Amorim Almeida, Ana Emília Teixeira Brito, Aline Lopes Garcia Leal, Paulo Almeida Filho, Elba Etchebehere
    Clinical and Translational Imaging.2020; 8(5): 365.     CrossRef
  • Factors Associated with Health Behaviors in Thyroid Cancer Survivors
    Junghyun Yoon, Boyoung Park
    Journal of Cancer Prevention.2020; 25(3): 173.     CrossRef
  • Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening
    Luc H.J. Sondorp, Vivian M.L. Ogundipe, Andries H. Groen, Wendy Kelder, Annelies Kemper, Thera P. Links, Robert P. Coppes, Schelto Kruijff
    Cancers.2020; 12(11): 3212.     CrossRef
  • Hemithyroidectomy for Thyroid Cancer: A Review
    Noor Addasi, Abbey Fingeret, Whitney Goldner
    Medicina.2020; 56(11): 586.     CrossRef
  • Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis
    Jonghwa Ahn, Meihua Jin, Eyun Song, Min Ji Jeon, Tae Yong Kim, Jin-Sook Ryu, Won Bae Kim, Young Kee Shong, Ji Min Han, Won Gu Kim
    Endocrinology and Metabolism.2020; 35(4): 830.     CrossRef
  • Clinical Significance of Gross Invasion of Strap Muscles in Patients With 1- to 4-cm-Sized Papillary Thyroid Carcinoma Undergoing Lobectomy
    Eyun Song, Won Woong Kim, Min Ji Jeon, Tae-Yon Sung, Dong Eun Song, Tae Yong Kim, Ki Wook Chung, Won Bae Kim, Young Kee Shong, Suck Joon Hong, Yu-Mi Lee, Won Gu Kim
    Annals of Surgical Oncology.2019; 26(13): 4466.     CrossRef
  • Lobectomy Is Feasible for 1–4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence
    Eyun Song, Minkyu Han, Hye-Seon Oh, Won Woong Kim, Min Ji Jeon, Yu-Mi Lee, Tae Yong Kim, Ki Wook Chung, Won Bae Kim, Young Kee Shong, Suck Joon Hong, Tae-Yon Sung, Won Gu Kim
    Thyroid.2019; 29(1): 64.     CrossRef
  • Laser and radiofrequency ablations for benign and malignant thyroid tumors
    Giovanni Mauri, Nicolò Gennaro, Min Kyoung Lee, Jung Hwan Baek
    International Journal of Hyperthermia.2019; 36(2): 13.     CrossRef
  • US-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: Efficacy and Safety in a Large Population
    Hyun Kyung Lim, Se Jin Cho, Jung Hwan Baek, Kang Dae Lee, Chang Woo Son, Jung Min Son, Seon Mi Baek
    Korean Journal of Radiology.2019; 20(12): 1653.     CrossRef
  • Utility of Early Postoperative Unstimulated Thyroglobulin in Influencing Decision Making in Patients with Papillary Thyroid Carcinoma
    Alexandria D. McDow, Cynthia M. Shumway, Susan C. Pitt, David F. Schneider, Rebecca S. Sippel, Kristin L. Long
    Annals of Surgical Oncology.2019; 26(12): 4002.     CrossRef
  • Extent of Surgery for Low-Risk Differentiated Thyroid Cancer
    Alexandria D. McDow, Susan C. Pitt
    Surgical Clinics of North America.2019; 99(4): 599.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism